Jillian Shapiro, Ph.D., brings a deep understanding of the life sciences field to pharmaceutical clients seeking to protect their intellectual property.

Known for her ability to analyze the details of highly complex scientific innovations, Jill helps pharmaceutical companies, start-ups, universities, and other clients in the life sciences industry achieve optimal coverage of their clinical candidates and products. In addition to preparing and prosecuting patent applications, Jill manages portfolios; performs due diligence, freedom to operate, and landscape analyses; and provides general patent counseling in the biotechnology arts.

Jill is particularly renowned for her expertise in vaccines, viral vectors, RNA therapeutics, and protein therapeutics. In 2013, she was named to the Forbes 30 under 30: Science and Healthcare list for her doctoral research on the interplay between the host anti-virus response and small RNA production. She also has extensive experience working with antibodies, peptides, lipid nanoparticles, cell therapies (T-cells, CARs), and companion diagnostics, and she regularly manages patent portfolios for products undergoing clinical trials in the oncological, antimicrobial, ophthalmological, metabolic disease, and cardiovascular spaces.

Jill also has experience working with clients involved in a merger or acquisition. Most recently, she assisted in the patent due diligence surrounding the $70 million acquisition of a biopharmaceutical company focused on the development of novel antibody therapeutics.

Jill received her B.A. in biochemistry from New York University, her Ph.D. in biomedical sciences from Icahn School of Medicine at Mount Sinai (Department of Microbiology), and her J.D. from Fordham University School of Law. A former competitive skier, Jill uses her time outside the office each winter to hit the slopes.

Pro bono activities

  • Jillian has pro bono experience in the areas of immigration asylum and humanitarian parole applications.